Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other



Langermann Sol Create: Alert

All | News | Filings
Date FiledTypeDescription
03/01/2023 4 Langermann Sol (Chief Scientific Officer) has filed a Form 4 on NextCure, Inc.
Txns: Granted 135,000 options to buy @ $1.55, valued at $209.3k
02/02/2022 4 Langermann Sol (Chief Scientific Officer) has filed a Form 4 on NextCure, Inc.
Txns: Granted 117,400 options to buy @ $5.57, valued at $653.9k
03/16/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/03/2020 4 Langermann Sol (Chief Scientific Officer) has filed a Form 4 on NextCure, Inc.
Txns: Granted 78,200 options to buy @ $41.76, valued at $3.3M

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy